Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
09/2000
09/05/2000US6114316 Combination of bisphosphonate and tetracycline
09/05/2000US6113948 Microparticles and their use in wound therapy
09/05/2000US6113932 Nontoxic vernix compositions and method of producing
09/05/2000US6113922 Alkalosis in tissues for wound healing and carbon dioxide
09/05/2000US6113903 Antidiabetic agents
09/05/2000US6113899 Antagonists of chaperonin 10
09/05/2000US6113898 Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies
08/2000
08/31/2000WO2000050639A2 Gene sequence variations with utility in determining the treatment of disease
08/31/2000WO2000050562A2 Dna encoding snorf25 receptor
08/31/2000WO2000050453A1 A novel inhibitor of programmed cell death
08/31/2000WO2000050400A1 2-aminopyridines containing fused ring substituents
08/31/2000WO2000050070A2 Preparation for the treatment of pigmentation disorders
08/31/2000WO2000050047A2 Composition for the treatment of psoriasis
08/31/2000WO2000025805A8 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2
08/31/2000WO2000012074A3 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
08/31/2000DE19908242A1 Composition for treating pigmentation disorders, e.g. vitiligo, containing the protein DCoH, or related nucleic acids, antibodies or antisera
08/31/2000CA2363621A1 A novel inhibitor of programmed cell death
08/31/2000CA2363036A1 Composition for the treatment of psoriasis
08/31/2000CA2362906A1 Dna encoding snorf25 receptor
08/31/2000CA2362533A1 Gene sequence variations with utility in determining the treatment of disease
08/30/2000EP1031578A2 High purity albumin production by a multistep process
08/30/2000EP1031348A2 Interleukin-4 production inhibitors
08/30/2000EP1031347A1 Transnasal transport/immunisation with highly adaptable carriers
08/30/2000EP1030914A2 Antisense oligonucleotides against tenascin for treating vitiligo
08/30/2000EP1030867A1 Mammalian milk growth factor
08/30/2000EP1030851A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
08/30/2000EP1030845A1 Heterocyclic compounds having mmp and tnf inhibitory activity
08/30/2000EP1030842A1 Metalloproteinase inhibitors
08/30/2000EP1030840A1 Cyclic amine derivatives and their use as drugs
08/30/2000EP1030836A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
08/30/2000EP1030835A2 Urea derivatives and their use as integrin inhibitors
08/30/2000EP1030834A1 Benzocycloheptene derivatives
08/30/2000EP1030666A1 Novel use of compounds for anti-pruritic activity
08/30/2000EP1030664A1 Pharmaceutical compositions containing zafirlukast
08/30/2000EP1030662A2 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists
08/30/2000EP1030661A1 N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA 2? INHIBITORS
08/30/2000EP0998251A4 Compositions and methods for inhibiting photoaging of skin
08/30/2000EP0799198B1 Anti-inflammatory compounds
08/30/2000EP0668772B1 Specific immune system modulation
08/30/2000EP0248819B2 Recombinant fibroblast growth factors
08/30/2000CN1265027A Mild, rinse-off antimicrobial liquid cleansing compsns.
08/30/2000CN1264593A Medicine for treating dermatopathy and preparing process thereof
08/30/2000CN1264592A Medicine for treating ichthyosis and preparing process thereof
08/30/2000CN1264591A Medicine for treating psoriasis and preparing process thereof
08/30/2000CN1264590A Medicine for treating leukoderma and preparing process thereof
08/30/2000CN1264589A Medicine for treating leukoderma and preparing process
08/30/2000CN1264585A Exterior-applied Chinese-medicinal liniment for treating alopecia areata, seborrheic alopecia and bald
08/30/2000CN1264577A Face-care, skin protective compsns. containing succinic hydrochloric acid compound
08/30/2000CN1264574A Cosmetic compsns. containing phenylethylene ethylene/propenoic acid ester copolymer and fat phase
08/30/2000CN1055921C Derivative of vitamin D system which is modified in 20-position, prepn. of same and pharmaceutical made of same
08/30/2000CN1055855C Eexternal-use medicine for curing scars
08/29/2000US6110964 For treating arthritis, inflammatory bowel disease, crohn's disease, emphysema, acute respiratory distress syndrome, asthma chronic obstructive pulmonary disease, alzheimer's disease, organ transplant toxicity, cachexia, cancer
08/29/2000US6110944 LTA4, hydrolase inhibitors
08/29/2000US6110939 As a substance p antagonists treating tachykinin-mediated disease, asthma, central nervous system disorder
08/29/2000US6110933 Amino acid derivatives and their use as phospholipase A2 inhibitor
08/29/2000US6110747 Compounds and methods for modulating tissue permeability
08/29/2000US6110478 Oral carotenoid of carotene compounds
08/29/2000US6110475 Compostion, barrier film, and method for preventing contact dermatitis
08/24/2000WO2000049144A2 Pyk2 binding proteins
08/24/2000WO2000049135A2 Substrate for cell growth
08/24/2000WO2000049015A1 Pyridine compounds and their pharmaceutical use
08/24/2000WO2000048989A1 Mevinolin derivatives
08/24/2000WO2000048625A2 Inhibitors for use in hemostasis and immune function
08/24/2000WO2000048623A1 Novel amide derivatives as growth hormone secretagogues
08/24/2000WO2000048615A2 TREATMENT OF CHRONIC VIRAL INFECTIONS WITH $i(M. VACCAE)
08/24/2000WO2000048610A1 Chemical compounds
08/24/2000WO2000048609A1 Chemical compounds
08/24/2000WO2000048595A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen
08/24/2000WO2000048591A1 Combinations for the treatment of diseases involving angiogenesis
08/24/2000WO2000048590A1 Substituted stilbene compounds with vascular damaging activity
08/24/2000WO2000048581A2 Use of 5-ht3 receptor antagonists for treating musculoeskeletal diseases
08/24/2000WO2000048570A1 Pharmaceutical composition for balanic transmucosal administration of alfuzosin
08/24/2000WO2000048567A1 Method and composition for treating acne
08/24/2000WO2000048566A1 Skin preparations for external use
08/24/2000WO2000048558A1 Modified calycins
08/24/2000WO2000048554A2 Synergistic antimicrobial skin washing compositions
08/24/2000WO2000037470A8 Antihistaminic spiro compounds
08/24/2000WO2000031051B1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
08/24/2000WO2000023095A3 Method of modulating hair growth
08/24/2000WO2000020434A9 Cadherin-like asymmetry protein-1, and methods for its use
08/24/2000WO2000015797A3 Compositions and methods for the treatment of immune related diseases
08/24/2000WO2000013654A3 A carotenoid composition containing phytoene and phytofluene
08/24/2000WO2000010611A3 Drug targeting
08/24/2000WO1999034763A3 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis
08/24/2000DE4193302C2 Verwendung rekombinanter Antikörper spezifisch für TNF-alpha Using recombinant antibody specific for TNF-alpha
08/24/2000CA2363670A1 Chemical compounds
08/24/2000CA2362943A1 Pyk2 binding proteins
08/24/2000CA2362330A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen
08/24/2000CA2362306A1 Chemical compounds
08/24/2000CA2362290A1 Novel amide derivatives as growth hormone secretagogues
08/24/2000CA2362284A1 Modified calycins
08/24/2000CA2361925A1 Treatment of chronic viral infections with m. vaccae
08/24/2000CA2361273A1 Inhibitors for use in hemostasis and immune function
08/23/2000EP1028974A1 Secreted proteins and polynucleotides encoding them
08/23/2000EP1028957A1 Piperidine derivatives and their use as tachykinin antagonists
08/23/2000EP1028951A1 Diaryl-5-alkyl-5-methyl-2(5h)-furanones as selective cyclooxygenase-2 inhibitors
08/23/2000EP1028945A1 Substituted pyridine compounds as anti-inflammatory agents
08/23/2000EP1028753A1 Delivery of poly (ethylene glycol) -conjugated molecules from degradable hydrogels
08/23/2000EP1028741A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
08/23/2000EP1028731A2 Stable antiandrogenic gel composition
1 ... 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 ... 1065